about
Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skippingTestis-specific protein, Y-encoded (TSPY) expression in testicular tissuesEvidence for a common ethnic origin of cystic fibrosis mutation 3120+1G-->A in diverse populationsGenome-wide association studies identify four ER negative-specific breast cancer risk lociEpigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerGenome-wide association study identifies novel breast cancer susceptibility lociNetwork-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskDo MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathwaysLarge-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repairCandidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer riskGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSLarge-scale genotyping identifies 41 new loci associated with breast cancer risk.Identification of seven new prostate cancer susceptibility loci through a genome-wide association studySeven prostate cancer susceptibility loci identified by a multi-stage genome-wide association studyA genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.Common variants at 19p13 are associated with susceptibility to ovarian cancer.Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European DescentNo Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association ConsortiumAssessing the genetic architecture of epithelial ovarian cancer histological subtypes.No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Mutation analysis of the MDM4 gene in German breast cancer patientsHeterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.Hereditary breast cancer: ever more pieces to the polygenic puzzle.Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients.Novel and characteristic CFTR mutations in Saudi Arab children with severe cystic fibrosis.A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.Frequency of BRCA1 mutation 5382insC in German breast cancer patients.Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line.CFTR gene mutations and male infertility.Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.Neuregulin-1, the fetal endothelium, and brain damage in preterm newborns.Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium.A-TWinnipeg: Pathogenesis of rare ATM missense mutation c.6200C>A with decreased protein expression and downstream signaling, early-onset dystonia, cancer, and life-threatening radiotoxicityFunctional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers.New mutations in the ATM gene and clinical data of 25 AT patients.
P50
Q24291081-F3327CF0-D83E-411F-92E7-E85C8468B276Q24321469-579820F7-DDA8-4AFF-AAFE-E8220085755FQ24539127-8CAA7C89-4A38-4016-AEE5-B451BEB13894Q24622610-F10773BC-02F9-49BE-AFC1-070610B92698Q24633316-9EDB9538-130B-4869-8873-350801F58743Q24645441-80424408-A0DB-47E1-A016-A0717F05832DQ26799669-C34A4D9D-279C-49BD-9C73-6DCA1F77255BQ27851413-42A70F28-D9D8-4BA5-ABC2-2B621FD242F6Q28243858-E7F007F2-8CFD-467C-8434-53A5BB5FA92FQ28267893-8504F385-59AF-4BAD-873F-E5DA3407F9C8Q28385765-EE89DF17-6E19-41AE-AD14-0E8AD83F27DFQ28388497-0E546576-FCDF-4387-B645-0E25D1E8434EQ28584533-5720D9CD-1BEB-4BEA-BC3C-41B11099D34FQ29416989-23A44A82-23DA-472D-BF27-B436E43ABE44Q29417022-28994907-7F2A-4A5E-9BF9-E9130BED18D6Q29417074-13B2265F-AC7E-4A48-8D21-F944A4C3CC7DQ29417084-275B7EB0-6FFF-4D3C-A4FB-B853B5521BB3Q29417145-3D68B2AD-F688-4FE5-814D-8B38665651BDQ30000080-9F646CA6-9824-43A9-BDD0-C375ED58252AQ30275832-6ABDA75F-65A2-4352-BADE-C8A82EC0205FQ30276610-F3E9517E-7623-4E93-8F8B-CE9D5531AD9AQ30276986-A30630A3-780D-43D2-8C5A-995E755DCBCAQ30374367-F2957DC4-10E0-496B-B894-AB05A58F84A4Q31082788-401BE4F3-8011-4816-B2A4-FC2C71B84558Q33320072-731BA48A-6268-4597-9475-50BA5AA9A90CQ33330850-DE4C774A-2693-45A8-B26D-48AEF6DBB6C9Q33356511-BF753F77-7D61-43DC-A52F-B6543C2F1B59Q33627208-F7C9C3CB-353C-426F-AB1B-BF3923775F94Q33679861-75E446E3-0F9C-4966-B30B-10C54E401A63Q33747778-34C75ED0-00B3-4361-B602-EF67B220763EQ33778612-86D637C2-AD02-43F3-AC56-6AA8F66F5D57Q33853807-2FB6D8EF-1925-4B51-B01F-30D2094B035EQ33859206-48A7A44B-8A88-476E-B3A7-97D92E43E9F3Q33885830-00A913A9-1FF6-4BF3-99C2-1B07616636AFQ33885830-8A9E83F6-11DD-42DD-953F-44A049ED586FQ33894683-303626CC-2201-46D9-8F2B-138A71FE084DQ33912673-18FDACF1-145A-4CA1-8D8F-2DF3399BD2F0Q33921008-6A3ADCF6-4746-4A6C-AED8-790D4B41C3B4Q33960818-CC329057-3503-4627-87CC-FB17B85E6B1FQ34031757-FF0CB841-DD9D-4A67-BC1D-3F9525638F38
P50
description
Researcher
@en
onderzoeker
@nl
name
Thilo Dörk
@ast
Thilo Dörk
@en
Thilo Dörk
@nl
Thilo Dörk
@sl
type
label
Thilo Dörk
@ast
Thilo Dörk
@en
Thilo Dörk
@nl
Thilo Dörk
@sl
altLabel
Thilo Dörk-Bousset
@en
prefLabel
Thilo Dörk
@ast
Thilo Dörk
@en
Thilo Dörk
@nl
Thilo Dörk
@sl
P1053
J-8620-2012
P106
P21
P31
P496
0000-0002-9458-0282